Palovarotene Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Palovarotene Capsule (capsule) from Ipsen Biopharmaceuticals, Inc. with status To Be Discontinued. The shortage was first posted on Aug 31, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Ipsen Biopharmaceuticals, Inc.
- Package NDC
- 15054-0025-1
- Dosage Form
- Capsule
- Presentation
- SOHONOS, Capsule, 2.5 mg (NDC 15054-0025-1)
- Initial Posting
- Aug 31, 2026